Novartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook

(RTTNews) - Swiss drug major Novartis AG (NVS, NOVN.SW) reported Tuesday sharply lower profit in its third quarter, mainly hurt by an impairment charge and higher expenses,…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)